Innovative Pharma Inc.

GPTKB entity

Statements (59)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition gptkb:XYZ_Biotech
gptkbp:awards Best Innovative Company 2022
gptkbp:CEO gptkb:John_Doe
gptkbp:clinicalTrials Phase 3 Trials
Partnership_with_Research_Institute
gptkbp:collaborations Global Health Initiative
gptkbp:communityEngagement Health Awareness Campaigns
gptkbp:corporateSocialResponsibility Health Education Programs
Environmental Sustainability Projects
Community_Health_Initiatives
gptkbp:culturalHeritage Diversity Hiring Programs
Employee_Resource_Groups
gptkbp:customerBase Hospitals
Pharmacies
Healthcare_Providers
gptkbp:employees 500
gptkbp:financialPerformance Consistent Growth
Strong Profit Margins
gptkbp:founded 2001
gptkbp:futurePlans Invest in Technology
Increase Global Presence
Expand_Product_Line
gptkbp:headquarters gptkb:New_York,_USA
https://www.w3.org/2000/01/rdf-schema#label Innovative Pharma Inc.
gptkbp:investmentFocus Annual Reports
$50 million in R&D
Quarterly Earnings Calls
gptkbp:market gptkb:Asia
gptkb:North_America
Europe
New Vaccine 2021
New Antibiotic 2022
New Pain Relief Drug 2023
gptkbp:marketSegment Expansion_into_Asia
Focus_on_Biologics
gptkbp:partnerships gptkb:University_of_Medicine
gptkbp:patentCitation 20 active patents
gptkbp:philanthropy $5 million to local charities
gptkbp:products Antibiotics
Vaccines
Pain Relief Medication
gptkbp:regulatoryCompliance EMA_Approved
FDA_Approved
gptkbp:researchFocus Cancer Treatment
Diabetes_Management
gptkbp:researchInterest $10 million from NIH
gptkbp:revenue $200 million
gptkbp:socialMedia Facebook
LinkedIn
Twitter
gptkbp:specializesIn Biopharmaceuticals
gptkbp:supplyChain Local Distributors
Global Suppliers
Logistics_Partners
gptkbp:sustainabilityInitiatives Green Manufacturing Practices
gptkbp:training Leadership Development Programs
Continuous_Education_Programs
gptkbp:website www.innovativepharma.com